Motzer, R J <br/><br/>
Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Aug 1995 
 - 1950-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1995.13.8.1950  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Blotting, Northern<br/>Carcinoma, Renal Cell--drug therapy<br/>Combined Modality Therapy<br/>Drug Synergism<br/>Female<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--pharmacology<br/>Isotretinoin--pharmacology<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Receptors, Retinoic Acid--metabolism<br/>Recombinant Proteins<br/>Remission Induction<br/>Tumor Cells, Cultured--drug effects